DTC
Deep Track Capital’s Nurix Therapeutics NRIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69.1M | Buy |
6,064,910
+564,910
| +10% | +$6.43M | 2.22% | 17 |
|
|
2025
Q1 | $65.3M | Buy |
5,500,000
+2,500,000
| +83% | +$29.7M | 2.12% | 16 |
|
|
2024
Q4 | $56.5M | Sell |
3,000,000
-868,104
| -22% | -$16.4M | 2.11% | 13 |
|
|
2024
Q3 | $86.9M | Sell |
3,868,104
-123,396
| -3% | -$2.77M | 2.76% | 14 |
|
|
2024
Q2 | $83.3M | Buy |
3,991,500
+993,670
| +33% | +$20.7M | 2.49% | 17 |
|
|
2024
Q1 | $44.1M | Hold |
2,997,830
| – | – | 1.26% | 31 |
|
|
2023
Q4 | $30.9M | Hold |
2,997,830
| – | – | 1.03% | 38 |
|
|
2023
Q3 | $23.6M | Hold |
2,997,830
| – | – | 0.91% | 34 |
|
|
2023
Q2 | $29.9M | Hold |
2,997,830
| – | – | 1.39% | 22 |
|
|
2023
Q1 | $26.6M | Buy |
2,997,830
+731,261
| +32% | +$6.49M | 1.09% | 30 |
|
|
2022
Q4 | $24.9M | Buy |
2,266,569
+212,948
| +10% | +$2.34M | 1.04% | 33 |
|
|
2022
Q3 | $26.8M | Sell |
2,053,621
-382,543
| -16% | -$4.98M | 1.23% | 29 |
|
|
2022
Q2 | $30.9M | Buy |
+2,436,164
| New | +$30.9M | 2.03% | 19 |
|